drugset / Trial / NCT00000446

Drug Treatment for Alcoholics With Post-Traumatic Stress Disorder

NCT00000446

RandomizedDouble-blindTreatment

Summary

This study will investigate the use of sertraline (Zoloft) to decrease alcohol consumption and crime-related post-traumatic stress disorder in those individuals with both disorders. This will be a 12-week, placebo-controlled, double-blind outpatient trial. All subjects will receive cognitive behavioral therapy in addition to a placebo or sertraline. Comprehensive evaluation will be done at study entry; treatment termination; and 6, 9, and 12 months after study entry.

Timeline

Start
Primary completion
Completion
2000-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Sertraline Small molecule